title: In-vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus.
abstract: Blastoschizomyces capitatus represents an emerging fungal pathogen in acute leukemia patients. The susceptibility to amphotericin B, 5-fluorocytosine, ketoconazole and fluconazole of nine clinical isolates was evaluated. A specific medium (high resolution medium) was used for testing fluconazole. This agent and 5-fluorocytosine were at least four- to eight-fold more active than amphotericin B and ketoconazole against all isolates but one.
authors.affiliation: Patologia Medica II, Istituto di Clinica Medica VI, Università La Sapienza, Roma, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Venditti
authors.forename: B
authors.initials: B
authors.lastname: Posteraro
authors.forename: G
authors.initials: G
authors.lastname: Morace
authors.forename: P
authors.initials: P
authors.lastname: Martino
mesh_terms: D000935:Antifungal Agents / Q000494:pharmacology*; D015725:Fluconazole / Q000494:pharmacology*; D005848:Geotrichum / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D003904:Mitosporic Fungi / Q000187:drug effects*; D014250:Trichosporon / Q000187:drug effects
chemical_list: D000935:Antifungal Agents; D015725:Fluconazole